...
首页> 外文期刊>EFSA Journal >Modification of the conditions of the authorisation of BioPlus? 2B (Bacillus?licheniformis DSM 5749 and Bacillus?subtilis DSM 5750) for turkeys for fattening
【24h】

Modification of the conditions of the authorisation of BioPlus? 2B (Bacillus?licheniformis DSM 5749 and Bacillus?subtilis DSM 5750) for turkeys for fattening

机译:修改BioPlus授权的条件? 2B(地衣芽孢杆菌DSM 5749和枯草芽孢杆菌DSM 5750)用于肥育火鸡

获取原文
           

摘要

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the modification of the terms of the authorisation of BioPlus? 2B (Bacillus licheniformis DSM 5749 and Bacillus subtilis DSM 5750) in feeds for turkeys for fattening to allow the simultaneous use with a battery of permitted coccidiostats (diclazuril, halofuginone, monensin sodium, robenidine hydrochloride, maduramicin ammonium, lasalocid sodium) and with the preservative formic acid. The proposed modification in the conditions of the authorisation would not modify the conclusions previously drawn regarding the safety of the additive. The additive is safe for the target species, consumers and the environment. The additive should be considered a potential respiratory sensitiser, but the Panel could not conclude on the irritancy of the additive to skin and eyes or its dermal sensitisation. Conclusions previously drawn by the FEEDAP Panel on the compatibility of the additive for chickens for fattening apply to the current application provided that the maximum authorised concentration of the coccidiostats semduramycin, maduramicin ammonium, lasalocid sodium and the preservative formic acid for turkeys for fattening (when maximum authorised concentrations exist), are equal or lower than those for chickens for fattening. Considering the data submitted, the FEEDAP Panel concludes that BioPlus? 2B (B. licheniformis DSM 5749 and B. subtilis DSM 5750) is compatible with diclazuril and monensin sodium. Based on the data provided, no conclusion can be drawn for robenidine hydrochloride. In the absence of data, no conclusion can be drawn for halofuginone.
机译:应欧洲委员会的要求,动物饲料中使用的添加剂和产品或物质小组(FEEDAP)被要求就修改BioPlus?授权条款提出科学意见。火鸡饲料中添加2B(地衣芽孢杆菌DSM 5749和枯草芽孢杆菌DSM 5750),以使其与一批允许使用的抗球虫药同时使用(地克拉唑,卤氟丁酮,莫能菌素钠,盐酸罗苯尼定,马杜霉素铵,拉索拉西丁钠和拉索拉西钠)甲酸。在授权条件下的拟议修改不会修改先前得出的有关添加剂安全性的结论。该添加剂对目标物种,消费者和环境都是安全的。该添加剂应被视为潜在的呼吸道致敏剂,但专家小组无法就该添加剂对皮肤和眼睛的刺激性或对皮肤的致敏性得出结论。 FEEDAP专家组先前得出的关于用于育肥的鸡的相容性的结论适用于当前应用,前提是最大许可浓度的球虫抗药性塞达霉素,马杜菌素铵,拉索洛西钠和用于火鸡育肥的防腐甲酸(最大时)。存在授权浓度),等于或低于育肥鸡的浓度。考虑到提交的数据,FEEDAP小组认为BioPlus? 2B(地衣芽孢杆菌DSM 5749和枯草芽孢杆菌DSM 5750)与地克珠利和莫能菌素钠兼容。根据提供的数据,无法得出盐酸罗苯替丁的结论。在没有数据的情况下,无法得出氟氟龙酮的结论。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号